Net Income
Net Income
United Therapeutics Net Income decreased by 24.5% to $274.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.7%, from $322.20M to $274.90M. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 29.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
Detailed definition
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
Peer comparison
The most common metric for evaluating company performance against industry competitors.
Metric ID:
net_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $172.60M | $162.70M | $112.20M | $239.90M | $116.00M | $239.30M | $132.10M | $240.90M | $259.20M | $267.60M | $217.10M | $306.60M | $278.10M | $309.10M | $301.30M | $322.20M | $309.50M | $338.70M | $364.30M | $274.90M |
| QoQ Change | — | -5.7% | -31.0% | +113.8% | -51.6% | +106.3% | -44.8% | +82.4% | +7.6% | +3.2% | -18.9% | +41.2% | -9.3% | +11.1% | -2.5% | +6.9% | -3.9% | +9.4% | +7.6% | -24.5% |
| YoY Change | — | — | — | — | -32.8% | +47.1% | +17.7% | +0.4% | +123.4% | +11.8% | +64.3% | +27.3% | +7.3% | +15.5% | +38.8% | +5.1% | +11.3% | +9.6% | +20.9% | -14.7% |
Range$112.20M – $364.30M
CAGR+10.3%
Avg YoY Growth+22.1%
Median YoY Growth+13.7%
Net Income at Other Companies
Frequently Asked Questions
- What is United Therapeutics's net income?
- United Therapeutics (UTHR) reported net income of $274.90M in Q1 2026.
- How has United Therapeutics's net income changed year-over-year?
- United Therapeutics's net income decreased by 14.7% year-over-year, from $322.20M to $274.90M.
- What is the long-term trend for United Therapeutics's net income?
- Over 4 years (2021 to 2025), United Therapeutics's net income has grown at a 29.4% compound annual growth rate (CAGR), from $475.80M to $1.33B.
- What does net income mean?
- The total profit remaining after all costs, expenses, and taxes have been paid.